Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAY
BAYER AG SPONS ADR
BAY
|
+$535M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$124M |
| 3 |
Banco Bradesco
BBD
|
+$98.1M |
| 4 |
Itaú Unibanco
ITUB
|
+$94.1M |
| 5 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRXL
Parexel International Corp
PRXL
|
+$184M |
| 2 |
IRY
SPDR S&P International Health Care Sector
IRY
|
+$143M |
| 3 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$72.5M |
| 4 |
PNC Financial Services
PNC
|
+$31M |
| 5 |
HDFC Bank
HDB
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.92% |
| 2 | Technology | 13.57% |
| 3 | Healthcare | 12.73% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Diageo
DEO
$49.5B
| $1.92M | ﹤0.01% |
14,560
-214
| -1% | -$27.7K |
|
452
Booking.com
BKNG
$150B
| $1.91M | ﹤0.01% |
26,075
+1,200
| +5% | +$91K |
|
|
NPTN
453
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.91M | ﹤0.01% |
343,595
| – | – |
|
454
AeroVironment
AVAV
$7.42B
| $1.9M | ﹤0.01% |
+35,190
| New | +$1.5M |
|
|
IMGN
455
DELISTED
Immunogen Inc
IMGN
| $1.9M | ﹤0.01% |
248,576
-7,630
| -3% | -$50.7K |
|
|
IFX
456
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $1.9M | ﹤0.01% |
75,428
-191
| -0.3% | -$4.8K |
|
457
Travere Therapeutics
TVTX
$5.33B
| $1.88M | ﹤0.01% |
+75,645
| New | +$1.67M |
|
458
Puma Biotechnology
PBYI
$402M
| $1.86M | ﹤0.01% |
+15,545
| New | +$1.45M |
|
|
IRBT
459
DELISTED
iRobot
IRBT
| $1.85M | ﹤0.01% |
24,069
-4,814
| -17% | -$441K |
|
|
PGNX
460
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.85M | ﹤0.01% |
251,930
+89,808
| +55% | +$570K |
|
|
MNTA
461
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.82M | ﹤0.01% |
+98,523
| New | +$1.65M |
|
462
Lowe's Companies
LOW
$118B
| $1.8M | ﹤0.01% |
22,574
+745
| +3% | +$57K |
|
463
Lantheus
LNTH
$6.58B
| $1.8M | ﹤0.01% |
+101,043
| New | +$1.78M |
|
|
ACET
464
DELISTED
Aceto Corp
ACET
| $1.74M | ﹤0.01% |
154,668
+16,650
| +12% | +$230K |
|
465
Stewart Information Services
STC
$2.08B
| $1.7M | ﹤0.01% |
45,067
+6,624
| +17% | +$258K |
|
466
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $1.67M | ﹤0.01% |
31,780
-6,164
| -16% | -$325K |
|
|
SIGM
467
DELISTED
Sigma Designs Inc
SIGM
| $1.67M | ﹤0.01% |
264,744
| – | – |
|
468
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $1.65M | ﹤0.01% |
6,569
-4,755
| -42% | -$1.17M |
|
|
ARRY
469
DELISTED
Array Biopharma Inc
ARRY
| $1.65M | ﹤0.01% |
134,180
| – | – |
|
470
Incyte
INCY
$24.9B
| $1.64M | ﹤0.01% |
14,022
-1,510
| -10% | -$191K |
|
471
Heron Therapeutics
HRTX
$94.1M
| $1.62M | ﹤0.01% |
+100,364
| New | +$1.57M |
|
472
Petrobras Class A
PBR.A
$109B
| $1.59M | ﹤0.01% |
164,202
-642
| -0.4% | -$5.59K |
|
473
VanEck Vietnam ETF
VNM
$502M
| $1.49M | ﹤0.01% |
100,100
| – | – |
|
474
Clorox
CLX
$11.7B
| $1.48M | ﹤0.01% |
11,227
+8,698
| +344% | +$1.17M |
|
475
Expeditors International
EXPD
$21.8B
| $1.45M | ﹤0.01% |
24,145
+1,675
| +7% | +$95.9K |
|
Similar funds
Ken Fisher's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Fisher held 922 positions worth $71.3B, up 7.5% from $66.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher's Q3 2017 filing shows 120 new, 343 increased, 284 reduced and 79 closed positions. Its largest new stake was Coresite Realty Corporation: 286,849 shares worth $32.1M. The largest sale was Parexel International Corp, an estimated $184M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q3 2017 buy was Coresite Realty Corporation: 286,849 shares worth $32.1M.
- Ken Fisher added most to BAYER AG SPONS ADR in Q3 2017, an estimated $535M increase.
- Ken Fisher's biggest Q3 2017 reduction was PNC Financial Services, cutting an estimated $31M.
- Ken Fisher fully exited Parexel International Corp in Q3 2017, selling an estimated $184M.
- Ken Fisher's ten largest holdings make up 23% of its $71.3B portfolio in Q3 2017.
- Ken Fisher opened 120 new positions and closed 79 in Q3 2017.
- Ken Fisher's portfolio value rose 7.5% quarter-over-quarter to $71.3B.
Based on Fisher Asset Management's 13F filing for Q3 2017, filed 17 Oct 2017.